Schedule 13G ownership disclosure

SYROS PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 87184Q107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,315,000
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000230
Form type
SC 13G
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Apr 02, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub